Results 331 to 340 of about 242,891 (382)

Effectiveness of EMAS: A case study of Polish organisations registered under EMAS

Environmental Impact Assessment Review, 2019
Balanced economic growth in line with environmental care is one of the greatest challenges facing the world nowadays. Entrepreneurs' interest in sustainable production schemes, including Environmental Management Systems (EMS), becomes an important part ...
Alina Matuszak-Flejszman, Lara Johannsdottir   +1 more
exaly   +2 more sources

Validation of the Persian Version of the Engagement in Meaningful Activities Survey (EMAS) in an Iranian Stroke Population: Predictors of Participation in Meaningful Activities.

American Journal of Occupational Therapy, 2022
IMPORTANCE The inability to participate in meaningful activities is one of stroke survivors' main difficulties and has a negative effect on their satisfaction and quality of life.
Moslem Cheraghifard, M. Akbarfahimi, A. Azad, A. Eakman, G. Taghizadeh   +4 more
semanticscholar   +1 more source

The EMAS impasse: Factors influencing Italian organizations to withdraw or renew the registration

Journal of Cleaner Production, 2018
Roberto Merli, Michele Preziosi
exaly   +2 more sources

Persepsi Masyarakat Indonesia Terhadap Kenaikan Harga Emas Sebagai Instrumen Investasi Jangka Panjang: Sebuah Tinjauan Literatur

Future Academia : The Journal of Multidisciplinary Research on Scientific and Advanced
Penelitian ini bertujuan untuk mengkaji persepsi masyarakat Indonesia terhadap kenaikan harga emas sebagai instrumen investasi jangka panjang.
Rizaldi Siagian
semanticscholar   +1 more source

ANALISIS PERAMALAN HARGA EMAS DI INDONESIA PADA MASA PANDEMI COVID-19 UNTUK INVESTASI

Jurnal Litbang Sukowati : Media Penelitian dan Pengembangan, 2021
Pandemi Coronavirus Disease-2019 (Covid-19) merupakan kejadian yang tidak biasa. Adanya Covid-19 membuat masyarakat ragu dalam melakukan investasi. Hal ini dikarenakan kondisi perekonomian dunia tidak sedang dalam kondisi baik.
Dyah Makutaning Dewi, Muhammad Zaky Nafi', N. Nasrudin   +2 more
semanticscholar   +1 more source

EMAS position statement: Thyroid disease and menopause.

Maturitas
INTRODUCTION Thyroid diseases are common in women in their late reproductive years; therefore, thyroid disease and menopause may co-exist. Both conditions may present with a wide range of symptoms, leading to diagnostic challenges and delayed diagnosis ...
G. Mintziori, S. Veneti, Kris Poppe, D. Goulis, E. Armeni, C. Erel, Ivan Fistonić, Timothy Hillard, Angelica Lindén Hirschberg, Błażej Męczekalski, Nicolás Mendoza, A. Mueck, T. Simoncini, Petra Stute, Dorenda van Dijken, M. Rees, Leonidas Duntas, I. Lambrinoudaki   +17 more
semanticscholar   +1 more source

Menopause and diabetes: EMAS clinical guide.

Maturitas, 2018
INTRODUCTION Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independently of ageing has been a matter of debate. Controversy also exists about the benefits and risks of menopausal hormone therapy (MHT) in women with T2DM.
R. Słopień, E. Wender-Ożegowska, A. Rogowicz-Frontczak, B. Męczekalski, D. Zozulinska-Ziolkiewicz, J. Jaremek, A. Cano, P. Chedraui, D. Goulis, P. Lopès, G. Mishra, A. Mueck, M. Rees, L. Senturk, T. Simoncini, J. Stevenson, P. Stute, P. Tuomikoski, S. Paschou, P. Anagnostis, I. Lambrinoudaki   +20 more
semanticscholar   +1 more source

EMA-FAMS

Multiple sclerosis (MS) is a progressive autoimmune and neurodegenerative disease. One of the major symptoms of MS is fatigue which interferes individually with daily life activities and declines performance during tasks. Measuring associations between fatigue and activity performance (i.e., activity-related fatigability) in real-life situations ...
Suikkanen, Sara, Romberg, Anders, Feys, Peter, Myin-Germeys, Inez, Hämäläinen, Päivi, Rintala, Aki, Löppönen, Antti   +6 more
openaire   +1 more source

Fostering EMA's transparency policy

European Journal of Internal Medicine, 2014
The European Medicines Agency has opened a window to access clinical trial data. This is an important step forward which deserves attention, support, and advice from all the stakeholders. Regulatory agencies are the most comprehensive repositories of clinical trial data on drugs and can also promote and develop standard practices for data sharing.
Rita, Banzi, Vittorio, Bertele', Jacques, Demotes-Mainard, Silvio, Garattini, Christian, Gluud, Christine, Kubiak, Christian, Ohmann   +6 more
openaire   +2 more sources

EMAS Advert

Journal of Chromatography A, 2003
  +8 more sources